Registered number: 14937682
For the Year Ended 31 December 2025
New Global Consortium Limited
Company Information
New Global Consortium Limited
Contents
New Global Consortium Limited
Group Strategic Report
For the Year Ended 31 December 2025
The directors present their strategic report accompanying the consolidated financial statements for the year ended 31 December 2025.
Following a year of transition for the Group in 2024 where the business completed the fit out of and subsequent move into the new warehouse in Crawley, along with the full integration of Nexon which came into the group in 2023, the business appointed a number of key Senior Leadership hires roles Q1 of 2025 to further support and accelerate both top line and bottom line growth.
Despite some early market headwinds (with National Living Wage and National Insurance increases impacting customer budgets from April) the business reported solid top line growth of 3.9% on the back of some major customer wins, notably in the second half of the year, with 2026 benefitting from a full year of these contracts.
In addition, with increased focus on key profit drivers and strong cost control the business was able to improve Net Margins to 3.3%. As a result of these changes, along with prior year integration / dual running costs dropping out of the P&L, the business was able to report EBITDA of £4.26m, being 117% up on 2024.
From a Balance Sheet perspective, a focus on working capital throughout the year (particularly focussing on inventory levels), enabled the business to improve its net cash position by December 31st to £931,742.
Whilst market conditions remain competitive, the market fundamentals remain strong. The Directors believe that the customer wins secured in the second half of 2025 along with the continued improvements being driven by the management team and a clear strategy for the future, that with its market leading position Blueleaf is in a strong position to continue its recent momentum through 2026 and beyond.
Despite some early market headwinds (with National Living Wage and National Insurance increases impacting customer budgets from April) the business reported solid top line growth of 3.9% on the back of some major customer wins, notably in the second half of the year, with 2026 benefitting from a full year of these contracts.
In addition, with increased focus on key profit drivers and strong cost control the business was able to improve Net Margins to 3.3%. As a result of these changes, along with prior year integration / dual running costs dropping out of the P&L, the business was able to report EBITDA of £4.26m, being 117% up on 2024.
From a Balance Sheet perspective, a focus on working capital throughout the year (particularly focussing on inventory levels), enabled the business to improve its net cash position by December 31st to £931,742.
Whilst market conditions remain competitive, the market fundamentals remain strong. The Directors believe that the customer wins secured in the second half of 2025 along with the continued improvements being driven by the management team and a clear strategy for the future, that with its market leading position Blueleaf is in a strong position to continue its recent momentum through 2026 and beyond.
Principal risks and uncertainties, not already dealt with elsewhere in this report include:
Geopolitical Risk
Recent activities in the Middle East have highlighted the geopolitical risk to both prices and supply chains. The direct and indirect impact of disruption to the availability of oil and oil based products has the potential to put significant pressure on product availability and input prices. This needs to be managed proactively with our supply partners, and sensitively with our customers to ensure minimal disruption to our services.
Competitive and market risk
Continued demographic trends show an expected growth in the population of those over the age of 65 by 2043, and we still consider that the UK care market will see similar levels of growth over its timeframe making it an attractive market.
Whilst inflation pressures have eased significantly since the peaks of 2022/2023, the macro environment remains uncertain – with continuing Tariff noise emanating from the US creating considerable trading uncertainty globally. This has the potential to impact Blueleaf input prices – particularly for products sourced internationally from China and the Far East. To mitigate these risks the business is tracking key external metrics carefully so that any material changes to cost prices can be addressed promptly.
Credit risk
We have continued to work closely with our customers and suppliers to ensure that bad debts have been kept to a minimum and that suppliers were paid promptly.
There has been no significant deterioration in our bad debt experience and we have maintained a healthy credit rating.
Geopolitical Risk
Recent activities in the Middle East have highlighted the geopolitical risk to both prices and supply chains. The direct and indirect impact of disruption to the availability of oil and oil based products has the potential to put significant pressure on product availability and input prices. This needs to be managed proactively with our supply partners, and sensitively with our customers to ensure minimal disruption to our services.
Competitive and market risk
Continued demographic trends show an expected growth in the population of those over the age of 65 by 2043, and we still consider that the UK care market will see similar levels of growth over its timeframe making it an attractive market.
Whilst inflation pressures have eased significantly since the peaks of 2022/2023, the macro environment remains uncertain – with continuing Tariff noise emanating from the US creating considerable trading uncertainty globally. This has the potential to impact Blueleaf input prices – particularly for products sourced internationally from China and the Far East. To mitigate these risks the business is tracking key external metrics carefully so that any material changes to cost prices can be addressed promptly.
Credit risk
We have continued to work closely with our customers and suppliers to ensure that bad debts have been kept to a minimum and that suppliers were paid promptly.
There has been no significant deterioration in our bad debt experience and we have maintained a healthy credit rating.
Page 1
New Global Consortium Limited
Group Strategic Report (continued)
For the Year Ended 31 December 2025
A consolidated profit before tax of £2.2m (2024: loss of £0.66m) was recorded for the year to 31 December 2025.
Management considers the following to be the key performance indicators:
Management considers the following to be the key performance indicators:
The directors believe the Group will trade successfully for the foreseeable future and is actively seeking to grow its revenues and profits through 2026 and beyond.
The Board of Directors of New Global Consortium Limited consider that they have fulfilled their individual and collective duty under section 172(1) of the Companies Act 2006 to act in the way they consider, in good faith, would be most likely to promote the success of the Company for the benefit of shareholders in decisions made in the year to 31 December 2025. Details on how the directors and the Company engage with stakeholders in order to promote the succes of the Company is set out within the Directors' Report.
This report was approved by the board and signed on its behalf.
Page 2
New Global Consortium Limited
Directors' Report
For the Year Ended 31 December 2025
The directors present their report and the financial statements for the year ended 31 December 2025.
The directors are responsible for preparing the Group Strategic Report, the Directors' Report and the consolidated financial statements in accordance with applicable law and regulations.
In preparing these financial statements, the directors are required to:
∙select suitable accounting policies for the Group's financial statements and then apply them consistently;
∙make judgments and accounting estimates that are reasonable and prudent;
∙state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The principal activity of the Group is the distribution of cleaning, hygiene and janitorial products to professional users and to the care industry in the UK.
The profit for the year, after taxation, amounted to £1,008,848 (2024 - loss of £1,062,451).
During the year no dividend was paid (2024: £nil). The directors do not recommend the payment of a final dividend (2024: £nil).
The directors who served during the year were:
Page 3
New Global Consortium Limited
Directors' Report (continued)
For the Year Ended 31 December 2025
The financial statements have been prepared on the going concern basis as the directors have a reasonable expectation that the Company and Group will continue in operational existence for the foreseeable future.
New Global Consortium Limited (trading as Blueleaf) has a strong reputation as a leader in the supply of consumables to the UK Care industry, and this has been built around the way it builds long-term relationships with both its customers and its key suppliers.
Customers
Day-to-day engagement with customers is through the Blueleaf Hub, an online platform enabling orders to be placed at individual care home level which are then fulfilled according to agreed service metrics. The Hub provides a range of training, support materials and analytics to help support customers with day-to-day enquiries.
The business also has a Customer Services team for customers to engage with for initial queries and support, along with a team of account managers to provide the broader partnership approach that the business provides - working to focus on the things that make a difference to the care industry:
• effective cost management
• service levels through premium logistics
• expertise you can trust
Blueleaf also regularly undertakes surveys to ensure it is at the very least meeting customers expectations.
Suppliers
Blueleaf works with manufacturers across the UK, Europe and the Far East to source, stock and supply a full range of both branded and own brand consumables to the care industry. The business has invested in developing strong long-term relationships with selected quality suppliers through an extremely professional procurement team to ensure Blueleaf becomes a customer of choice with these suppliers, ensuring reliability of supply and quality of product for all our customers.
Employees
At Blueleaf, our success is driven by the expertise, creativity and dedication of our people, underpinned by our values; Stronger together, Lead the way, Achieve the outcome and Care, always. We consistently seek feedback from our employees via regular surveys, hold forums with staff and regularly communicate – to ensure we do everything we can to invest in our staff and improve employees’ experience with the business.
Customers
Day-to-day engagement with customers is through the Blueleaf Hub, an online platform enabling orders to be placed at individual care home level which are then fulfilled according to agreed service metrics. The Hub provides a range of training, support materials and analytics to help support customers with day-to-day enquiries.
The business also has a Customer Services team for customers to engage with for initial queries and support, along with a team of account managers to provide the broader partnership approach that the business provides - working to focus on the things that make a difference to the care industry:
• effective cost management
• service levels through premium logistics
• expertise you can trust
Blueleaf also regularly undertakes surveys to ensure it is at the very least meeting customers expectations.
Suppliers
Blueleaf works with manufacturers across the UK, Europe and the Far East to source, stock and supply a full range of both branded and own brand consumables to the care industry. The business has invested in developing strong long-term relationships with selected quality suppliers through an extremely professional procurement team to ensure Blueleaf becomes a customer of choice with these suppliers, ensuring reliability of supply and quality of product for all our customers.
Employees
At Blueleaf, our success is driven by the expertise, creativity and dedication of our people, underpinned by our values; Stronger together, Lead the way, Achieve the outcome and Care, always. We consistently seek feedback from our employees via regular surveys, hold forums with staff and regularly communicate – to ensure we do everything we can to invest in our staff and improve employees’ experience with the business.
Page 4
New Global Consortium Limited
Directors' Report (continued)
For the Year Ended 31 December 2025
For the year ended 31 December 2025 the Group has complied with the requirements of the Streamlined Energy and Carbon Reporting (SECR) regulations. The Group's greenhouse gas emissions and energy consumption for the year are shown in the table below:
Total Energy Consumption (kWh)
∙Electricity: 214346 kWh
∙Transport Fuel converted to kWh: 3,474,536
∙Total Energy Consumption (kWh)
Underlying Activity Data
∙Delivery Fuel Consumption: 335,704 litres
∙Business Travel: 250,955 miles
Methodology
The information disclosed above has been prepared in accordance with:
∙The Companies (Directors' Report) and (Energy and carbon Report) Regulations 2018
∙The GHG Protocol Corporate Accounting Standard
∙UK Government DEFRA emission factors (2025)
Scope 2 emissions are reported using the location-based method.
Scope 3 emissions for business travel have been calculated using the UK Government 2025 DEFRA conversion factor for average cars (0.28067 kg CO2e per mile).
Transport fuel has been converted to kWh using standard UK Government gross calorific values for diesel fuel (10.35 kWh per litre).
The organisational boundary includes all UK operations under the Company's operational control.
Intensity ratio
The Group has chosen tonnes of CO2 equivalent per 3 million of revenue as its intensity ratio, as this metric reflects business growth and allows for meaningful comparison over time.
Energy efficiency actions
The Company has undertaken the following energy efficiency initiatives during the year:
∙Procurement of electricity under renewable energy tariffs
∙Optimisation of delivery route planning to reduce fuel consumption
∙Phased upgrades to improve servicing fleet fuel efficiency
Page 5
New Global Consortium Limited
Directors' Report (continued)
For the Year Ended 31 December 2025
While these initiatives are expected to reduce emissions intensity over time, total emissions increased during the year due to higher operational activity and business growth.
Prior year comparison
Scope 1 emissions increased by approximately 20% year-on-year, primarily driven by increased delivery volumes and associated fuel usage as we increased own deliveries and reduced external (Scope 3 - out of scope) deliveries.
Scope 2 emissions decreased by approximately 14%, reflecting improved energy efficiency and increased sourcing of renewable electricity.
Scope 3 emissions decreased compared to the prior year due to reduced business travel mileage.
The Group continues to focus on fleet efficiency improvements, including the planned introduction of newer, more fuel-efficient vehicles in 2026.
Additional notes
Scope 1 emissions relate primarily to fuel consumption for company operated vehicles.
Scope 2 emissions relate to purchased electricity.
Scope 3 emissions relate to business travel in employee-owned vehicles (grey fleet).
The Company has chosen in accordance with the Companies Act 2006, s. 414C(11) to set out in the Group's strategic report information required by The Large and Medium sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of the review of business, principal risks and uncertainties and future developments.
The Group has no post balance sheet events to report.
The audit registration of Kreston Reeves LLP was transfered to Kreston Reeves Audit LLP on 6 October 2025. Kreston Reeves Audit LLP were formally appointed as auditor to the company on 6 October 2025.
The auditors, Kreston Reeves Audit LLP, will be proposed for reappointment in accordance with section 485 of the Companies Act 2006.
Page 6
New Global Consortium Limited
Directors' Report (continued)
For the Year Ended 31 December 2025
This report was approved by the board and signed on its behalf.
Page 7
New Global Consortium Limited
Independent Auditors' Report to the Members of New Global Consortium Limited
We have audited the financial statements of New Global Consortium Limited (the 'parent Company') and its subsidiaries (the 'Group') for the year ended 31 December 2025, which comprise the Consolidated Statement of Comprehensive Income, the Consolidated Balance Sheet, the Company Balance Sheet, the Consolidated Statement of Cash Flows, the Consolidated Statement of Changes in Equity, the Company Statement of Changes in Equity and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Page 8
New Global Consortium Limited
Independent Auditors' Report to the Members of New Global Consortium Limited (continued)
The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The directors are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
In our opinion, based on the work undertaken in the course of the audit:
∙the information given in the Group Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
∙the Group Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the Group and the parent Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Directors' Report.
Page 9
New Global Consortium Limited
Independent Auditors' Report to the Members of New Global Consortium Limited (continued)
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Group financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
Capability of the audit in detecting irregularities, including fraud
Based on our understanding of the company and the industry in which it operates, and through discussion with the directors and other management (as required by auditing standards), we identified that the principal risks of non-compliance with laws and regulations related to health and safety and employment law. We considered the extent to which non-compliance might have a material effect on the financial statements. We also considered those laws and regulations that have a direct impact on the preparation of the financial statements such as the Companies Act 2006, taxation and pension legislation. We communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit. We evaluated management’s incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls), and determined that the principal risks were related to posting inappropriate journal entries to revenue or expenditure and management bias in accounting estimates and judgemental areas of the financial statements such as the valuation of goodwill. Audit procedures performed by the engagement team included:
∙ Discussions with management and assessment of known or suspected instances of non-compliance with
laws and regulations (including health and safety) and fraud; and
laws and regulations (including health and safety) and fraud; and
∙ Assessment of identified fraud risk factors; and
∙ Identifying and assessing the design effectiveness of controls that management have in place to prevent
and detect fraud; and
and detect fraud; and
∙ Challenging assumptions and judgements made by management in its significant accounting estimates;
and
and
∙ Performing analytical procedures with automated data analytics tools to identify any unusual or
unexpected relationships, including related party transactions, that may indicate risks of material
misstatement due to fraud; and
unexpected relationships, including related party transactions, that may indicate risks of material
misstatement due to fraud; and
∙ Review of significant and unusual transactions and evaluation of the underlying financial rationale
supporting the transactions; and
supporting the transactions; and
∙ Identifying and testing journal entries, in particular any manual entries made at the year end for financial
statement preparation.
statement preparation.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance.
Page 10
New Global Consortium Limited
Independent Auditors' Report to the Members of New Global Consortium Limited (continued)
This report is made solely to the Company and the Group's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company and the Group's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Group and the Company and the Group's members, as a body, for our audit work, for this report, or for the opinions we have formed.
for and on behalf of
Statutory Auditor
Horsham
Page 11
New Global Consortium Limited
Consolidated Statement of Comprehensive Income
For the Year Ended 31 December 2025
Page 12
New Global Consortium Limited
Registered number: 14937682
Consolidated Balance Sheet
As at 31 December 2025
The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
The notes on pages 18 to 38 form part of these financial statements.
Page 13
New Global Consortium Limited
Registered number: 14937682
Company Balance Sheet
As at 31 December 2025
The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
The notes on pages 18 to 38 form part of these financial statements.
Page 14